Definitive Healthcare (NASDAQ:DH) Given New $6.00 Price Target at Stifel Nicolaus

Key Points

• Stifel Nicolaus raised the target price for Definitive Healthcare (NASDAQ:DH) from $5.00 to $6.00, indicating a potential upside of 45.53% based on its current trading price.
• Definitive Healthcare reported earnings of $0.05 per share for the last quarter, exceeding expectations, despite a 6.8% year-over-year decline in revenue.
• Multiple brokerages have differing opinions on the stock, with one upgrading it to a "buy" rating while another downgraded it to "neutral," resulting in an average rating of "hold."

Definitive Healthcare (NASDAQ:DH - Free Report) had its target price boosted by Stifel Nicolaus from $5.00 to $6.00 in a report issued on Friday,Benzinga reports. They currently have a buy rating on the stock.

Several other research firms also recently issued reports on DH. Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, The Goldman Sachs Group boosted their price target on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a report on Monday, May 12th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $4.90.

Definitive Healthcare Stock Down 2.8%

Definitive Healthcare stock traded down $0.11 during midday trading on Friday, hitting $3.86. 991,755 shares of the company were exchanged, compared to its average volume of 421,911. The company's fifty day moving average price is $3.89 and its 200-day moving average price is $3.61. The company has a market cap of $573.75 million, a PE ratio of -1.46, a price-to-earnings-growth ratio of 6.50 and a beta of 1.64. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. Definitive Healthcare has a fifty-two week low of $2.15 and a fifty-two week high of $5.68.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The firm had revenue of $59.19 million for the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a positive return on equity of 3.65% and a negative net margin of 124.43%. Definitive Healthcare's revenue for the quarter was down 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.08 EPS. On average, research analysts predict that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in DH. Wells Fargo & Company MN boosted its position in Definitive Healthcare by 27.4% during the 4th quarter. Wells Fargo & Company MN now owns 31,297 shares of the company's stock worth $129,000 after acquiring an additional 6,736 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Definitive Healthcare by 20.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after acquiring an additional 3,496 shares during the period. Northern Trust Corp boosted its position in Definitive Healthcare by 3.2% during the 4th quarter. Northern Trust Corp now owns 497,279 shares of the company's stock worth $2,044,000 after acquiring an additional 15,530 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Definitive Healthcare by 6.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock worth $334,000 after acquiring an additional 4,748 shares during the period. Finally, Geode Capital Management LLC boosted its position in Definitive Healthcare by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company's stock worth $5,231,000 after acquiring an additional 39,938 shares during the period. 98.67% of the stock is currently owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.